European Journal of Cancer
Volume 46, Issue 9 , Pages 1661-1667 , June 2010

Oxidative stress-induced antioxidant enzyme expression is an early phenomenon in ovarian carcinogenesis

  • Marjo Pylväs

      Affiliations

    • Department of Obstetrics and Gynecology, University of Oulu and Oulu University Hospital, Finland
    • Department of Oncology and Radiotherapy, University of Oulu and Oulu University Hospital, Finland
  • ,
  • Ulla Puistola

      Affiliations

    • Department of Obstetrics and Gynecology, University of Oulu and Oulu University Hospital, Finland
  • ,
  • Saila Kauppila

      Affiliations

    • Department of Pathology, University of Oulu and Oulu University Hospital, Finland
  • ,
  • Ylermi Soini

      Affiliations

    • Department of Pathology, University of Oulu and Oulu University Hospital, Finland
    • Department of Clinical Pathology and Forensic Medicine, University of Kuopio, Finland
  • ,
  • Peeter Karihtala

      Affiliations

    • Department of Obstetrics and Gynecology, University of Oulu and Oulu University Hospital, Finland
    • Department of Oncology and Radiotherapy, University of Oulu and Oulu University Hospital, Finland
    • Corresponding Author InformationCorresponding author: Address: Department of Oncology and Radiotherapy, P.O. Box 22, 90029 Oulu University Hospital, Finland. Tel.: +358 8315 2011; fax: +358 8 315 6449.

Received 7 December 2009 ,Accepted 5 February 2010.

References 

  1. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol. Cell Biochem. 2004;266:37–56
  2. Karihtala P, Soini Y. Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies. APMIS. 2007;115:81–103
  3. Rabilloud T, Heller M, Gasnier F, et al. Response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J. Biol. Chem. 2002;277:19396–19401
  4. Arnér ESJ, Holmgren A. The thioredoxin system in cancer. Semin. Cancer Biol. 2006;16:420–426
  5. Karihtala P, Soini Y, Vaskivuo L, Bloigu R, Puistola U. DNA adduct 8-hydroxydeoxiguanosine, a novel putative marker of prognostic significance in ovarian carcinoma. Int. J. Gynecol. Cancer. 2009;19:1047–1051
  6. Tavassoéli FA, Devilee P. Tumours of the breast and female genital organs. Lyon: IARC Press, WHO; 2003;
  7. Halliwell B. Biochemistry of oxidative stress. Biochem. Soc. Trans. 2007;35:1147–1150
  8. Evans MD, Dizdaroglu M, Cooke MS. Oxidative DNA damage and disease: induction, repair and significance. Mutat. Res. 2004;567:1–61
  9. Shen J, Deininger P, Hunt JD, Zhao H. 8-Hydroxy-2′-deoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer. Cancer. 2007;109:574–580
  10. Murawaki Y, Tsuchiya H, Kanbe T, et al. Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett. 2008;259:218–230
  11. Kondo S, Toyokuni S, Iwasa Y, et al. Persistent oxidative stress in human colorectal carcinoma, but not in adenoma. Free Radic. Biol. Med. 1999;27:401–410
  12. Karihtala P, Winqvist R, Syväoja JE, Kinnula VL, Soini Y. Increasing oxidative damage and loss of mismatch repair enzymes during breast carcinogenesis. Eur. J. Cancer. 2006;42:2653–2659
  13. Anttila MA, Voutilainen K, Merivalo S, et al. Prognostic significance of iNOS in epithelial ovarian cancer. Gynecol. Oncol. 2007;105:97–103
  14. Raspollini MR, Amunni G, Villanucci A, et al. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: correlation with clinical outcome. Gynecol. Oncol. 2004;92:806–812
  15. Ishii T, Yanagawa T. Stress-induced peroxiredoxins. Subcell. Biochem. 2007;44:375–384
  16. Neumann CA, Krause DS, Carman CV, et al. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defense and tumor suppression. Nature. 2003;424:561–565
  17. Turunen N, Karihtala P, Mäntyniemi A, et al. Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma. APMIS. 2004;112:123–132

PII: S0959-8049(10)00109-7

doi: 10.1016/j.ejca.2010.02.006

European Journal of Cancer
Volume 46, Issue 9 , Pages 1661-1667 , June 2010